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Abstract 
Liability to schizophrenia is inversely correlated with general cognitive ability at both the 
phenotypic and genetic level. Paradoxically, a modest but consistent positive genetic correlation has 
been reported between schizophrenia and educational-attainment, despite the strong positive genetic 
correlation between cognitive ability and educational-attainment. Here we leverage published GWAS in 
cognitive ability, education, and schizophrenia to parse biological mechanisms underlying these results. 
Association analysis based on SubSETs (ASSET), a pleiotropic meta-analytic technique, allowed jointly 
associated loci to be identified and characterized. Specifically, we identified subsets of variants 
associated in the expected (“Concordant”) direction across all three phenotypes (i.e., greater risk for 
schizophrenia, lower cognitive ability, and lower educational attainment); these were contrasted with 
variants demonstrating the counterintuitive (“Discordant”) relationship between education and 
schizophrenia (i.e., greater risk for schizophrenia and higher educational attainment). ASSET analysis 
revealed 235 independent loci associated with cognitive ability, education and/or schizophrenia at 
p<5x10−8. Pleiotropic analysis successfully identified more than 100 loci not significant in the input 
GWASs. Many of these have been validated by larger, more recent single-phenotype GWAS. Leveraging 
the joint genetic correlations of cognitive ability, education, and schizophrenia, we were able to 
dissociate two distinct biological mechanisms: early neurodevelopmental pathways that characterize 
concordant allelic variation, and adulthood synaptic pruning pathways that were linked to the 
paradoxical positive genetic association between education and schizophrenia. Further, genetic 
correlation analyses revealed that these mechanisms contribute not only to the etiopathogenesis of 
schizophrenia, but also to the broader biological dimensions implicated in both general health outcomes 
and psychiatric illness. 
Keywords: Cognitive ability, Educational attainment, Schizophrenia, GWAS, Pathways, Genetic 
correlation, pleiotropy 
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Introduction 
 
It has long been observed that impaired cognitive ability is a significant aspect of the illness in 
schizophrenia (MIM:181500)1–5. Cognitive deficits have been shown to be largely independent of clinical 
state and treatment status in patients with schizophrenia1,4,6–9, and are observed (in more subtle form) 
in their first-degree relatives10,11. Moreover, cognitive deficits precede illness onset by many years, 
beginning in early childhood5,12–14, resulting in reduced educational attainment in patients diagnosed 
with schizophrenia15,16.  
Unlike phenotypic correlation, which measures covariances between the distribution of the 
phenotypes, genetic correlation (rg) indexes the covariance between SNP ~ phenotype GWAS effect sizes 
across a pair of phenotypes measured in separate GWAS studies. Recent advances in psychiatric and 
cognitive genomics have reliably demonstrated that the inverse relationship between cognitive ability 
and risk for schizophrenia is also observed at the molecular genetic level (rg~-.20) 17–23. Paradoxically, 
genetic correlation studies have indicated a positive relationship between educational attainment and 
risk for schizophrenia (rg~.10)23,20,24–27, despite the fact that educational attainment and cognitive ability 
exhibit a very strong polygenic overlap (rg~.70)18,23,27. Educational attainment is often considered to be a 
proxy for cognitive ability; however, the lack of perfect genetic overlap between the two, combined with 
the paradoxical genetic correlation between educational attainment and schizophrenia, suggest an 
opportunity to decompose distinct genetic mechanisms accounting for this pattern of results. 
Whereas genetic correlation analysis has recently become widespread due to the availability of 
techniques such as linkage disequilibrium (LD) score regression (LDSC)25,28, these approaches generally 
result in a single, genome-wide estimate of polygenic overlap. Moreover, novel meta-analytic 
approaches (e.g., Multi-Trait Analysis of GWAS [MTAG]29) for merging seemingly heterogeneous GWAS 
datasets tend to exploit commonalities across phenotypes rather than differences; for example, two 
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recent studies have employed MTAG across the highly correlated cognitive and educational GWASs in 
order to accelerate the process of gene discovery18,23. By contrast, few studies have attempted to 
examine the counter-intuitive correlation between schizophrenia and educational attainment, or to 
parse subsets of SNPs that might drive cross-phenotype correlations. An initial effort has successfully 
identified a few individual loci that act in paradoxical fashion, increasing educational attainment while 
simultaneously increasing risk for schizophrenia30; two other studies have identified loci that 
demonstrate other pleiotropic effects19,31. 
To date, however, no studies have utilized pleiotropic meta-analytic techniques to 
comprehensively parse variance from cognitive, educational, and schizophrenia GWAS that may 
pinpoint differential biological mechanisms. In order for the paradoxical pattern of genomewide 
correlations to exist, there must be identifiable subsets of SNPs that are differentially involved in driving 
these genetic relationships. Therefore, we sought to identify differentially associated variants, as they 
may yield crucial insights into the fine-grained genetic architecture of schizophrenia, in turn giving us 
insights into the etiopathogenic mechanisms underlying the illness that standard GWAS cannot detect.  
In the present report, we first utilize a simple subsetting approach to identify SNPs that are 
significantly associated with either cognitive ability or educational attainment, but not both (Figure S1a). 
We hypothesized that these SNP subsets would demonstrate stronger genetic correlations with 
schizophrenia than observed with a simple genomewide approach. We then employ a pleiotropic meta-
analytic approach, ASSET32, which permits the characterization of each SNP with respect to its pattern of 
effects on multiple phenotypes (Figure S1b). For example, ASSET has previously been used to 
demonstrate that the minor allele of rs2736100 (at the TERT (MIM:187270) locus) is positively 
associated with risk for pancreatic cancer (MIM:260350), negatively associated with risk for kidney 
(MIM:144700) and lung cancers (MIM:211980), and not significantly associated with risk for cancers of 
the breast (MIM:114480), bladder (MIM:109800), and prostate (MIM:176207); other cancer loci were 
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demonstrated to have various other patterns of effects32. We utilized ASSET to identify two types of loci: 
1) those SNPs that are consistently associated with all three phenotypes in the expected direction (i.e., 
the same allele associated with higher cognitive ability, higher educational attainment, and lower risk 
for schizophrenia), which we label “Concordant”; and 2) SNPs that demonstrate the paradoxical 
association between education and schizophrenia (i.e., the same allele associated with higher 
educational attainment and higher risk for schizophrenia), labelled “Discordant.” Next, we compared the 
statistically significant ASSET results to the output of single trait GWASs of cognitive ability, educational 
attainment, or schizophrenia20,33,34, in order to identify novel loci suggested by ASSET.  Subsequently, we 
conducted a series of pathway and transcriptome-wide analyses to biologically characterize differential 
mechanisms underlying Concordant vs Discordant loci. Finally, we performed a series of genetic 
correlation analyses to compare the overlap of Concordant and Discordant SNP subsets with other 
relevant traits. Further analytic details are covered in the methodology section; the full analysis 
workflow is also represented in Figures S1-2. 
Methods 
Stage 1: Simple Subsetting Approach Based on P-values in Cognition and Education GWAS 
Note that for most purposes in this manuscript, we are using the largest GWAS for 
schizophrenia35, cognitive ability18, and educational attainment36 published prior to 2018. For each of 
these phenotypes, larger GWASs have been published in 2018; these were used for validation and 
extension as described in subsequent sections. Before any subsetting analyses, genome-wide genetic 
correlations were used to confirm the earlier observed genetic correlations between schizophrenia with 
both cognitive ability and education. In Stage 1, preliminary SNP subsets were formed simply based on 
p-value thresholds of cognitive ability and educational attainment GWAS: i) SNPs nominally associated 
with cognition (p < 0.05) and not associated with education (p > 0.05) were selected, resulting in 74,470 
SNPs; ii) SNPs nominally associated with cognition (p < 0.05) and not associated with education using a 
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stricter threshold (p > 0.5) resulted in 66,657 SNPs; iii) similar procedures were carried out for SNPs 
nominally associated with education (p < 0.05) but not cognition (p > 0.05), resulting in 104,807 SNPs; 
and iv) SNPs nominally associated with education (p < 0.05) and not cognition using a stricter threshold 
(p > 0.5), resulting in 44,803 SNPs.  
Next, we performed a heterogeneity test between results of cognitive and educational GWAS 
using METAL37, and generated sets of SNPs showing opposite effects between the two (i.e, the same 
allele predicts better cognitive performance but less educational attainment, and vice versa). We 
identified sets of SNPs of varying sizes based on varying p-value thresholds for the heterogeneity tests (p 
< .5; p < .25; p < .1; p < .05; p < .01; p < .001).  
To evaluate the degree of genetic correlation of these preliminary subsets of SNPs with respect 
to schizophrenia, we utilized GNOVA38, a recently published method similar to LD score regression. 
GNOVA is specifically designed to examine genetic correlations using SNP subsets (rather than global 
genome-wide summary statistics), whereas such applications have not been explicitly tested in LD score 
regression and may not be robust.  
 
Stage 2: ASSET Meta-Analysis and ASSET-generated SNP Subsets 
Schizophrenia GWAS summary statistics were obtained from the Psychiatric Genomics 
Consortium35 based on the European ancestry GWAS of schizophrenia (N = 77,096, Cases = 33,640, 
Controls = 43,456; GWAS mean χ2 = 1.677). To make them compatible with effect sizes (Beta weights) 
derived from the linear regression-based cognition and education GWASs, odds-ratios from the case-
control schizophrenia GWAS were converted to Beta by taking the natural logarithm. Effect direction per 
SNP was also reversed for schizophrenia to make them consistent with the interpretation of cognition 
and education (i.e., concordant alleles are those where the direction of effect is the same for cognitive 
ability, educational attainment, and for schizophrenia). Summary statistics for the education GWAS was 
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obtained from the Social Science Genomics Association Consortium (SSGAC)36 (N = 328,917, GWAS mean 
χ2 = 1.638). GWAS summary statistics for cognition are available via earlier inverse-variance meta-
analysis of samples18 from the COGENT27 consortium (N = 107,207, GWAS mean χ2 = 1.245). General 
quality control parameters were applied to the schizophrenia and cognitive GWAS summary statistics 
excluding SNPs with INFO scores < 0.6 and minor allele frequency < 0.01; multiple quality control 
parameters thresholds were previously reported for the education GWAS36 and summary statistics 
provided by the SSGAC. Detailed quality control and meta-analytic procedures were reported earlier18. 
Only SNPs that were present for all three phenotypes were retained as input to the ASSET meta-analysis, 
resulting in 7,306,098 SNPs for subsequent analysis.  
Pooling GWAS summary statistics using conventional inverse-variance meta-analysis increases 
power, but also poses methodological challenges when different studies are capturing 
heterogeneous/pleiotropic phenotypes. In the case of pleiotropy, individual variants are likely to be 
associated with only a subset of the traits analyzed, or may even demonstrate effects in different 
directions for the different phenotypes under analysis. ASSET meta-analysis32 is an agnostic approach 
that generalizes standard fixed-effects meta-analysis by allowing a subset of the input GWASs to have 
no effect on a given SNP, and exhaustively searches across all possible subsets of “non-null” GWAS 
inputs within a fixed-effect framework to identify the strongest association signal in both positive and 
negative directions. ASSET then evaluates the significance of these positive and negative associations 
while accounting for multiple testing. This methodology allows for a powerful pooled two-tailed Z-score 
test statistic that effectively combines p-values for variants with strong effects in opposite directions 
across input GWASs. ASSET also permits the addition of a covariance term for the adjustment of 
overlapping samples. The genetic correlation matrix between the three input GWAS had been added to 
all reported ASSET analyses, in order to perform this adjustment. Recently, comparisons between cross 
phenotype meta-analysis methodologies demonstrated that ASSET performed best as the number of 
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meta-analysed traits with null effects increases, along with specificity and sensitivity of the results; in 
addition the ASSET approach best controlled for potential Type 1 inflation due to sample overlap, and 
non-uniform distribution of effect sizes39.  As such we selected ASSET for its conservative effect 
estimates and minimal inflation for the purpose of the current report.  
GWAS summary statistics from schizophrenia, cognition, and education were combined using 
ASSET two-tailed meta-analysis (version 1.9.1) to obtain single cross phenotype pleiotropic GWAS 
results. Default parameters were carried out using the “h.traits” function. Inter-study correlations of the 
phenotype were first ascertained using linkage disequilibrium score regression (LDSC)25,28, which 
accounts for the genome-wide genetic correlation of the phenotypes as well as sample overlap. For each 
given SNP, ASSET generates Z-scores of effect size and p-values based on the strongest association from 
the input studies in positive and negative directions, respectively; then these p-values are pooled into a 
single two-tailed p-value for pleiotropy32,39. SNPs with similar relationships across the input traits 
(regardless of statistical significance) are then grouped into subsets identified by ASSET (see Figure 1b; 
Figure S1, bottom).  
Again, as noted above, it is important to emphasize that the per-SNP direction of effect was 
reversed for schizophrenia to make it consistent with the interpretation of cognition and education (i.e., 
higher scores are better, such that higher scores for schizophrenia are now coded as decreased risk for 
the disorder). Thus, in the notations to follow, a ‘∩’, represents variant subsets with the same effect 
directions, following the reversal of the direction of effect for the schizophrenia data set, and ‘|’, 
represent traits that goes in the opposite direction in terms of effect sizes compared to the other two 
traits (again following the reversal of the direction of effect for the schizophrenia data set). ASSET 
subsets included: i) scz ∩ edu ∩ cog (Concordant, variants with an allele associated with an increase in 
cognitive ability and educational attainment, but a decrease in schizophrenia risk); ii) edu ∩ cog | scz 
(Schizophrenia outlier, variants associated with an increase in cognitive ability and educational 
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attainment, but also an increase in schizophrenia risk); iii) scz ∩ cog | edu (Education outlier, variants 
associated with an increase in schizophrenia risk and reduced cognitive ability, but an increase in 
educational attainment); iv) scz ∩ edu | cog  (Cognition outlier, variants associated with an increase in 
schizophrenia risk and reduced educational attainment, but an increase in cognitive ability) subsets. 
ASSET also identified SNPs where only a single trait (scz or edu or cog) was significant; these were 
included in a category called ‘Single phenotype’.  
Finally, to generate an appropriate contrast for the ‘Concordant’ subset, we included a 
combined single ‘Discordant’ subset, representing the counter-intuitive genetic correlation between 
education and schizophrenia, where, ‘Discordant’ = (edu ∩ cog | scz) + (scz ∩ cog | edu) [subsets ii and 
iii above], regardless of the effect for cognition. These contrasts are also represented visually in Figure 1 
and Figure S1.  
 
Consolidation of Independent Loci  
 Independent genomewide significant loci for each ASSET meta-analysis subset were identified 
via SNP clumping procedures that are a part of the Functional Mapping and Annotation (FUMA) 
pipeline40. For the LD-rich MHC region, a single top SNP was retained. For all other loci, clumping 
procedures were carried out based on the European 1000 Genomes Project phase 3 reference panel. 
First, “independent significant SNPs” were defined as those SNPs with a p-value < 5×10−8 and with 
linkage disequilibrium r2 < 0.6 with other, more significant SNPs at the same locus. Second, candidate 
SNPs were then identified for subsequent annotations and were defined as all SNPs that had a MAF of 
0.01, a maximum p value of 0.05, and were in LD of r2 ≥ 0.6 with at least one of the independent 
significant SNPs. To ensure that biological annotation of these loci would not be hampered by poor 
coverage at any locus, candidate SNPs included SNPs from the 1000 Genomes reference panel that may 
not have been included in the ASSET data. Third, “lead SNPs” were defined as the independent 
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significant SNPs that had the strongest signal at a given locus and were strictly independent from each 
other (r2 < 0.1). Finally, risk loci that were 250kb or closer were merged into a single locus. The FUMA 
procedure was iterated across all ASSET SNP subsets, which were comprised (by definition) of non-
overlapping SNPs. Additional variant annotations were conducted with ANNOVAR41, and lookups with 
published GWAS were conducted using the GWAS catalog42. Additional SNP lookups were performed 
with the input summary statistics (Cognition, Education and Schizophrenia GWASs35,36,18), recent MTAG 
analysis of Intelligence43, recent Cognition/Intelligence20,21 GWASs, and pleiotropic analyses of cognition 
and schizophrenia19 as well as education and schizophrenia31. RAggr44 was utilized to extract SNPs within 
250kb and r2 > 0.6 from published reports to allow merging from loci generated from ASSET subsets.  
 
MAGMA Gene-based Analysis: Tissue Expression and Competitive Pathway Analysis 
SNPs were mapped to 19,436 protein coding genes using MAGMA, as implemented in the 
FUMA40 pipeline. MAGMA45 gene analysis was performed using default SNP-wide mean model using the 
1000 Genomes phase 3 reference panel and default gene annotations that are part of the FUMA 
pipeline. Genome-wide SNP p-values and SNP-level sample sizes were included in the input files. 
MAGMA gene tissue expression analysis was carried out utilizing the Genotype-Tissue Expression (GTEx; 
version 746–48) resource, examining the relationship between gene expression in a specific tissue type 
and ASSET results. The gene-property test was performed for average expression (log2 transformed 
RPKM with pseudocount 1 after winsorization at 50) of 53 specific tissue types conditioning on average 
expression across all tissue types.  
MAGMA competitive pathway analysis was also conducted with results that emerged from the 
ASSET analysis in order to identify specific biological processes linked to our sub-phenotypes of interest. 
Gene sets that were tested included drug-related pathways49,50, as well as custom-curated 
neurodevelopmental and other brain-related gene sets that had gone through stringent quality control 
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in a study originally designed to interrogate rare variants in schizophrenia51. In the latter, pathways with 
more than 100 genes from Gene Ontology (release 146; June 22, 2015 release), KEGG (July 1, 2011 
release), PANTHER (May 18, 2015 release), REACTOME (March 23, 2015 release), DECIPHER 
Developmental Disorder Genotype-Phenotype (DDG2P) database (April 13, 2015 release) and the 
Molecular Signatures Database (MSigDB) hallmark processes (version 4, March 26, 2015 release) were 
initially included. Brain-level tissue expression gene-sets included the Brainspan RNA-seq dataset52 and 
the GTEx v7 dataset46. MAGMA gene-based and gene-set analysis were conducted using MAGMA v1.645. 
Additional gene sets were selected based on risk for schizophrenia and neurodevelopmental disorders, 
including those reported for schizophrenia rare variants53 (translational targets of FMRP (MIM:309550), 
components of the post-synaptic density, ion channel proteins, components of the ARC, mGluR5, and 
NMDAR complexes, proteins at cortical inhibitory synapses, targets of mir-137, and genes near 
schizophrenia common risk loci) and autism (MIM:613436) risk (autism risk genes: targets of CHD8 
(MIM:610528), splice targets of RBFOX (MIM:605104), hippocampal gene expression networks, 
neuronal gene lists from the Gene2Cognition database, as well as “loss of function intolerant” genes 
(pLI > 0.9 from the ExAC v0.3.1 pLI metric), ASD risk genes for FDR < 10% and 30%, and 
ASD/developmental disorder de novo genes hit by a LoF or a LoF/missense de novo variant). Further 
details of curation of these gene sets was previously reported51.  
 
S-PrediXcan: Brain Tissue Expression Profiles and Hypergeometric Gene-set Enrichment Analysis 
Genetically regulated gene expression was imputed for the ASSET summary statistics using 
tissue models from GTEx v7 and the CommonMind Consortium via S-PrediXcan (formerly MetaXcan)54–
56. S-PrediXcan computes downstream phenotypic associations of genetic regulation of molecular traits 
using elastic nets, adjusting for model uncertainty and colocalization of GWAS and eQTL signals54. GTEx 
v7 tissue included amygdala (N = 88), anterior cingulate cortex (N=109), basal ganglia (N=144), 
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cerebellar hemisphere (N=125), cerebellum, cortex (N=136), frontal cortex (N=118), hippocampus 
(N=111), hypothalamus (N=108), nucleus accumbens (N=130), putamen (N=111), spinal cervical-1 
(N=83) and substantia nigra (N=80).  The CommonMind consortium data consist of tissue expression 
derived from the dorsolateral prefrontal cortex (DLPFC, N=279)57.  GTEX v7 Tissue expression models 
were trained using elastic net models that were made publicly available (see Web Resources). Elastic net 
models for DLPFC were contributed by collaborators from the CommonMind Consortium57–59. 
Bonferroni correction was first conducted for each ASSET subset of genes. Genes that survived multiple 
testing correction were entered to GENE2FUNC to conduct a test of over-representation, which is part 
of the FUMA40 pipeline. This analysis differs from the MAGMA gene set analysis as the MAGMA gene set 
analysis is used to examine if gene sets, united by a known biological theme, are enriched for the 
phenotype under investigation. In a test of overrepresentation, as conducted using GENE2FUNC, the 
shared function of the genes of interest is unknown, and its elucidation is the goal of a test of over-
representation. The over-representation test conducted using GENE2FUNC queries gene sets from the 
1) Molecular Signature Database (MsigDB v 5.2) 2) WikiPathways (Curated Version 20161010) and 3) 
GWAS Catalogue (reported genes ver e91 20180206); to avoid spurious results, we required a minimum 
of 3 genes per pathway. For each gene set, hypergeometric tests were conducted, examining the list of 
genes significant in each ASSET subset for overlap with gene sets within the databases stipulated above 
and applying Bonferroni correction for multiple testing. To reduce the likelihood that hypergeometric 
pathway analysis would be influenced by the dense number of genes within the MHC region, genes 
within the coordinates of 28,000,000 – 35,000,00060 on chromosome 6 were removed.  
Genetic Correlations 
 To examine how our ASSET Concordant and Discordant SNP subsets relate to other phenotypes 
with available GWAS data, we conducted genetic correlations using GNOVA38, an approach similar to LD 
score regression but capable of working with SNP subsets.  Notably, GNOVA provides a corrected rg that 
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has been demonstrated to be robust to sample overlaps, and is able to account for LD across SNPs 38. A 
series of neuropsychiatric, inflammatory, brain, metabolic and cardiovascular phenotypes that have 
been previously demonstrated to have genetic correlations with cognitive measures were selected to 
interrogate the genetic overlaps of our ASSET subsets.  Interpretation of GNOVA for the Concordant 
subset was straightforward, as the three input GWAS weights all follow the same direction (following 
the reverse-coding of schizophrenia as noted previously). By contrast, Discordant SNPs have two 
separate potential weights (allelic β for schizophrenia vs. allelic β for education); as shown in Figure 1B, 
a given SNP might have somewhat different effect sizes (distance from the center line) for education as 
compared to schizophrenia. Therefore, we weighted each SNP by the stronger value of β: variants for 
which the schizophrenia β was stronger than the education β were referred to as “schizophrenia type,” 
while variants with the opposite pattern were referred to as “education type.” Nevertheless, it is 
important to emphasize that the Discordant SNPs represent a single dimension of biology, and the net 
effects of all “schizophrenia type” variants were equivalent to the “education type” SNPs, albeit with 
opposite signs.  
 
Results 
Stage 1: Preliminary evaluation of genetic correlations  
 GWAS summary statistics for cognition (N = 107,207)18 and education (N = 328,917)36 were used 
to evaluate preliminary genetic correlations with schizophrenia (N = 77, 096)35. Consistent with previous 
results, the inverse genetic correlation using GNOVA, between cognition and schizophrenia was 
significant (rg = -.21, se = .03, p=1.12×10−12), as was the counter-intuitive positive correlation between 
education and schizophrenia (rg=.08, se=.02, p=2.05×10−5). Note that these analyses were conducted 
prior to reversing the direction of effect for schizophrenia. 
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Prior to the main ASSET analysis, two simple approaches were used to examine subsets of SNPs 
and their association with schizophrenia (Figure S1). First, we selected SNPs that were nominally 
associated with education (p < 0.05) and generally not associated with cognition (p > 0.05); GNOVA for 
this subset of educational attainment SNPs revealed a slightly stronger positive correlation rg of .17 
compared with genome-wide summary statistics of schizophrenia (Figure 2A). With a stricter threshold 
for SNPs not associated with cognition (p > 0.50), these “non-cognitive” educational attainment SNPs 
also attained an rg of .17 with schizophrenia. GNOVA analyses were repeated for SNPs nominally 
associated with cognition (p < 0.05), but generally not associated with education (p > 0.05), and then 
repeated again with the stricter threshold for education (p > 0.50). Values for rg of -.50 and -.11 were 
obtained between schizophrenia and these cognition subsets (Figure 2a).  
The second approach involved calculating the heterogeneity p-values for cognition and 
education, identifying SNPs that have discrepant direction of effects between cognition and education. 
These SNPs are then binned, ranging from low probability (p < 0.5) to high probability (p < 0.001) for 
heterogeneous effect sizes between cognition and education (Figure 2b). GNOVA indicated that the 
greater the discrepancy in effect direction between SNP effects for cognition and education, the 
stronger the association between cognition and schizophrenia. However, this pattern was not observed 
for education and schizophrenia.  
 
Stage 2: ASSET Meta-Analysis and SNP subsets 
 Genome-wide cross-phenotype ASSET meta-analysis across 7,306,098 SNPs revealed 300 lead 
SNPs across 236 independent loci that met the genomewide significance threshold of p <5×10−8 for the 
ASSET 2-tailed test (see Figure 3A and Tables S1 and S2). There were 1,381,020 SNPs that demonstrated 
consistent direction of effects between cognition, education and schizophrenia (i.e., lower cognitive 
ability, lower educational attainment, and increased risk for schizophrenia); these were assigned to the 
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“Concordant” subset, which contained 89 genomewide significant loci harboring 103 independent 
significant SNPs. By contrast, the “Discordant” subset, which consisted of SNPs with counter-intuitive 
allelic effects for schizophrenia vis-à-vis education, encompassed 1,891,743 SNPs, with 65 genomewide 
significant loci comprising 77 independent significant SNPs (Figures 3B and 3C ; Table S1). Significant loci 
for other ASSET subsets are also detailed in Table S2, along with FUMA-derived annotations for potential 
functional consequences, including CADD scores (Table S3), eQTL lookups (Table S4), and prior GWAS 
lookups (Table S5). 
 
Consolidation of Independent Loci  
Next, we wanted to identify which loci from our ASSET results were not previously identified 
with respect to the three input GWAS. Using RAggr44 we extracted SNPs with r2 > 0.6 within a window of 
250kb of lead SNPs in reported GWAS i.e. 101 loci from the European-ancestry cohorts of the Psychiatric 
Genomics Consortium GWAS of schizophrenia35, 74 loci from the SSGAC educational attainment GWAS36 
and 40 loci from the COGENT GWAS of cognitive ability18. These were merged with the 236 loci from 
ASSET. As earlier described, independent loci within 250kb were merged, resulting in 280 independent 
loci being identified across ASSET and the input GWAS. As shown in the resulting Venn diagram (Figure 
4), 110 loci were identified by the ASSET meta-analysis, not earlier reported. By contrast, 126 loci 
overlapped with either schizophrenia, education or schizophrenia, while 44 loci were only significant in 
the input GWAS but not ASSET.  
Very recently, new GWAS have been published for schizophrenia, cognitive ability, and 
educational attainment, which are larger than the input GWAS used for our ASSET analysis20,33,34. This 
permitted us to perform a lookup of our 110 “novel” ASSET SNPs, thus providing an opportunity to 
validate ASSET as a tool for locus discovery (Table S6). We also performed lookup in a paper utilizing 
MTAG to examine intelligence20 or several recent papers using pleiotropic approaches to these 
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phenotypes19,31,43. We found that 75% of the loci were in fact reported as significant in the later GWASs 
with larger sample sizes, while 28 of the 110 loci were independent from other single-phenotype GWAS 
reports. These  loci are reported in Table 1. Notably, 3 of these loci (indexed by rs207338, rs708212, and 
rs11617058) were identified in secondary analyses (using MTAG) performed in the study of educational 
attainment34, and one locus (rs67652508) has been reported as genomewide significant for association 
to putamen volumes as measured on magnetic resonance imaging scans of the brain61. Further 
ANNOVAR41 annotations are available for novel loci (Table S7). 
 
MAGMA Gene-based Analysis: Tissue expression and Competitive Pathway Analysis 
MAGMA gene-based analysis was conducted on all ASSET subsets. 772 genes survived 
Bonferroni correction in the overall ASSET analysis, with 306 genes in the Concordant subset and 304 
genes within the Discordant subset (Table S8). MAGMA gene property analysis revealed significant 
association (p < 0.000926, Bonferroni-corrected) of gene expression of ASSET SNP subsets across GTExv7 
brain tissues (Figure S3, Table S9). There were no significant differences between Concordant and 
Discordant result subsets; both subsets were significantly enriched (positive Beta weights) across all 
brain compartments. 
 Because of the significant enrichment in brain tissues, we next performed MAGMA competitive 
pathway analyses using neurodevelopmental and other brain-related gene sets as curated in a recent 
publication51; full results are reported in Table S10. Although there was considerable overlap of pathway 
enrichment across ASSET categories, several gene sets were uniquely associated with either the 
Concordant or Discordant result subsets (Table 2). Specifically, the CHD8 pathway, reflecting genes 
involved in early neurodevelopment, was uniquely associated with the Concordant subset (p = 
7.11×10−6). By contrast, a number of synaptic pathways (e.g. ion channel, synaptic density) and 
constrained gene sets appeared to be uniquely associated with the Discordant subset. Only two gene 
21 
 
sets were enriched in both the Concordant and Discordant results, and these were rather generic: brain-
enriched genes, and schizophrenia GWAS results (Table S10). It is notable that when the MHC region is 
removed from the pathway analysis, the overall pattern of results remained (See Table S10).  
To see if the Concordant/Discordant distinction harbors potential implications for drug targeting 
(for schizophrenia and/or cognitive enhancement), we performed drug-based and drug family 
competitive gene set analysis on our MAGMA results. These analyses revealed that the class of drugs 
associated with voltage-gated calcium channel genes was over-represented amongst the Discordant 
subset results (Bonferroni-corrected p=0.02), as was Abacavir (nucleoside reverse transcriptase 
inhibitor; Bonferroni-corrected p=0.00018). While both of these sets showed similar direction of effects 
with respect to the Concordant subset, no drug-related gene sets attained Bonferroni-corrected 
significance in the Concordant set of results (Table S11).  
 
S-Predixcan: Brain tissue expression profiles and gene-set enrichment analysis 
 Transcriptome-wide association analysis (TWAS) was carried out via S-Predixcan to identify top 
expressed genes within GTEXv747 and CommonMind Consortium55,57–59 brain tissue models (Figure 5; 
Table S12). The top brain expressed genes unique to the Discordant subsets were CYP21A1P 
(MIM:613815), CFB (MIM:138470), and C4A (MIM:120810), along with 177 additional genes significantly 
expressed in the Discordant, but not Concordant, subsets. On the other hand ELOVL7 (MIM:614451) , 
NAGA (MIM:609241) and 201 other genes were uniquely associated with the Concordant subset. 
Significant genes identified by S-Predixcan were subjected to gene-set analysis using GENE2FUNC 
hypergeometric gene set analysis (excluding MHC genes, which were over-represented due to significant 
linkage disequilibrium, see Methods for more details). The goal of this analysis was to examine if the 
genes identified in the TWAS overlapped with those found in known biological systems. As shown in 
Table 3, the results of the TWAS consistently identified genes found in cell adhesion and membrane 
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protein gene sets for the Concordant subset. By contrast, synaptic (specifically, dendritic) pathways, as 
well as chromosomal repair pathways were consistently identified by the TWAS when examining the 
Discordant subset.  
 
Genetic Correlations 
  A series of psychiatric, personality, structural brain imaging, and metabolic, cardiovascular and 
anthropometric traits were selected for GNOVA modelling with the ASSET subset results (See Figure 6, 
Table S13); multiple testing was adjusted using false discovery rate (FDR).The Concordant subset 
demonstrated significant (FDR<.05) genetic correlations, in the expected direction, with many forms of 
psychopathology in addition to schizophrenia (ADHD [MIM:143465], bipolar disorder [MIM: 125480], 
and MDD [MIM: 608516], as well as neuroticism and smoking). This subset also demonstrated a 
significant (FDR<.05) positive genetic correlation (i.e., better cognition/higher education/lower risk for 
schizophrenia) with larger volumes of several brain regions (including total intracranial volume) as 
measured by structural MRI, as well as several measures of infant size and adult height. Significant 
positive associations were also seen with the personality dimensions of openness and 
conscientiousness, and (surprisingly) self-reported cancer; significant negative associations were seen 
for total cholesterol and triglycerides, as well as presence of ulcerative colitis/inflammatory bowel 
disease. Additionally, a negative genetic correlation was observed for the Concordant subset with BMI 
and measures of cardiovascular disease (i.e., lower cognition/lower education/greater risk for 
schizophrenia associated with greater BMI and risk for cardiovascular disease).  
 The Discordant subset was strongly associated with schizophrenia and education, by definition, 
in a manner demonstrating the paradoxical relationship (higher education, greater risk for schizophrenia 
(Figure 6). (It is important to note that the light blue bars and dark blue bars in Figure 6 are essentially 
mirror images of each other and are therefore providing somewhat redundant information; both sets of 
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bars are included to indicate the both sides of this dimension). Interestingly, a similar pattern was 
observed for bipolar disorder (higher education/greater risk for schizophrenia – greater risk for bipolar 
disorder). Similar relationships were also observed, at a nominally significant level, for autism spectrum 
disorder and eating disorders (MIM: 606788), which were not associated with the concordant subset, as 
well as MDD. The reverse relationship, however, was observed with ADHD (i.e., higher 
education/greater risk for schizophrenia – lower risk for ADHD). This pattern was also observed for the 
smoking, BMI, and cardiovascular disease phenotypes. A counter-intuitive pattern was observed for the 
relationship between the Discordant subset and neuroticism, which was the opposite of that observed 
for MDD (despite the fact that MDD and neuroticism are themselves highly correlated).  
 
Discussion 
 
A consistent finding in recent schizophrenia, cognitive, and educational GWAS has been the 
involvement of both neurodevelopmental pathways and synaptic processes19,20,39,63,64; the present 
study aimed to at least partially disentangle these mechanisms. In this study, we leveraged the genetic 
pleiotropy underlying three partially overlapping, complex phenotypes in order to identify 
homogeneous subsets of SNPs with distinct characteristics. Specifically, we were able to parse a subset 
of SNPs with alleles that were associated in the expected fashion across our three phenotypes of 
interest: lower cognitive ability, lower educational attainment, and greater risk for schizophrenia.  These 
“Concordant” SNPs were characterized by their association with genes and pathways relevant to early 
neurodevelopmental processes. By contrast, SNPs that demonstrated a counterintuitive, discordant 
pattern of association (higher educational attainment yet greater risk for schizophrenia), were primarily 
associated with genes/pathways involved in synaptic function of mature neurons.   
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This distinction was robustly observed across several methods of functional annotation. First, 
MAGMA competitive gene-set analysis revealed a significant enrichment of CHD8-related genes in the 
Concordant subset (Table 2). CHD8, encoding a chromatin remodeling protein, is a gene that has been 
robustly associated with autism64–67, but to date has only limited or anecdotal evidence for association 
to schizophrenia68,69. Disruption of the homologous gene (Chd8) in animal models has demonstrated 
that the resulting protein plays a key role in very early neurodevelopmental processes, including 
neuronal proliferation and differentiation70,71, as well as cell adhesion and axon guidance72. On the other 
hand, MAGMA competitive gene-set analysis revealed a significant enrichment of discordant genes for 
functions including synaptic transmission and the postsynaptic density, as well as membrane 
depolarization and voltage-gated cation channel activity.  While these processes have been commonly 
associated with both schizophrenia33,35 and cognitive phenotypes20,21,24,73–76, our study is the first to 
demonstrate that these synaptic mechanisms operate in a surprising manner: the same synaptic 
functions that increase risk for schizophrenia also serve to enhance educational attainment.  
The linkage of early neurodevelopmental processes to SNPs associated with impaired cognition 
and increased risk for schizophrenia is consistent with a large literature demonstrating that cognitive 
deficits are often observed early on in the lifespan of these individuals13,14,77,78. At the same time, the 
Discordant variant subset implicates more mature neuronal regulation, and synaptic pruning 
mechanisms that are most prominent later in childhood, adolescence, and into adulthood, ostensibly as 
part of a neuroplasticity mechanism to make more “efficient” connections within the brain79. However, 
the dysregulation of such mechanisms have been shown to be intricately linked to schizophrenia 
psychopathology80. It is important to note that these results are obtained from separate GWASs of two 
different phenotypes, and do not represent a subset of highly educated patients with schizophrenia. 
Rather, it is plausible to posit an inverted U relationship, such that efficient synaptic pruning processes 
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are essential mechanisms underlying academic performance, but may be carried too far in disorders 
such as schizophrenia.  
Additionally, transcriptome-wide analysis using S-Predixcan pointed towards the same 
distinction between Concordant and Discordant genes and pathways. Two of the strongest genes with 
differential expression in the Concordant subset were NAGA (an enzyme cleaving specific moieties from 
glycoconjugates) and NDUFAF2 (part of the mitochondrial complex [MIM: 609653]); rare mutations in 
each of these genes are associated with early and severe neurodevelopmental disorders81,82. TWAS of 
the discordant subset revealed synaptic genes including C4A, which plays a key role in synaptic 
pruning80, as well as other transcripts essential to synapse structure and function such as ARL3 (MIM: 
604695), FXR1 (MIM: 600819), and CNNM2 (MIM: 607803). Moreover, pathway analysis of S-Predixcan 
results (Table 3) demonstrated that the strongest gene set associated with the Concordant subset was 
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742), which encompasses 
processes such necessary for neural tube closure, cerebral cortex migration, and neuronal-glial 
interactions. By contrast, the Discordant subset transcriptome was significantly enriched for genes 
located at dendrites, as well as DNA repair. Recently, the role of DNA repair in modulating neuronal 
activity-induced gene expression has been shown to be crucial for synaptic plasticity and related 
processes of learning and memory83; impairments in DNA repair have been linked to 
neurodegeneration84,85 
ASSET also permitted the identification of SNPs for cognition-related phenotypes. Lookups of 
the full ASSET results revealed that ~75% of the additional 110 loci, not identified in the input GWAS 
studies18,35,36, were in fact replicated in by an MTAG study examining intelligence20 and more recent 
follow-up GWAS20,33,34 with larger samples that were more well powered for variant discovery. This 
result strongly supports the validity of the ASSET methodology, and demonstrates that the approach 
indeed improves power for cross-phenotype discovery of new loci as previous discussed by the 
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developers of the method32. Notably, several of our loci were associated with eQTLs suggesting new 
potential biological mechanisms for individual variation in cognitive and psychiatric phenotypes. For 
example, one of the loci strongly implicates variation in PLXNB2 (MIM: 604293), a gene associated with 
GABA and glutamate synapses in the hippocampus86. Another locus shows strong eQTL signal with NDE1 
(MIM: 609449), a neurodevelopmental gene at the 16p13.11 locus, where copy number variants have 
been associated with neurodevelopmental disorders87.  
 Our work supports and extends a recent study by Bansal and colleagues30, which is the only 
published report (to our knowledge) that has deeply examined the paradoxical relationship between 
educational attainment and schizophrenia. Using a proxy-phenotype approach, these investigators 
identified two loci, implicating the FOXO6 (MIM: 611457) and SLITRK1 (MIM: 609678) genes, with 
pleiotropic (i.e., “discordant”) effects across the two phenotypes. Using ASSET, we also uncovered those 
genes amongst our 110 loci (one of which was also not identified in any of the updated single-
phenotype GWAS, see Table 1). Several other studies18,19,31,43 have employed other statistical 
approaches to identify pleiotropy and/or overlap across cognitive/educational and schizophrenia GWAS, 
uncovering a subset of the loci identified by ASSET. By utilizing ASSET, we were able to systematically 
and powerfully identify concordant and discordant pleiotropic loci across the genome, and to then 
characterize underlying biological mechanisms. Future studies could also apply ASSET and related 
techniques to further understand other reported polygenic overlaps, such as that between 
schizophrenia and creativity88, or between cognitive ability and smoking status26. 
In addition to functional characterization using pathway analyses, we were able to characterize 
the Concordant and Discordant SNP sets with respect to genetic overlap with other relevant 
phenotypes. To our knowledge, this is the first study to examine genetic correlations with dimensional 
sub-sets, rather than global correlations with full GWAS. While the Concordant subset followed the 
expected patterns of genetic correlation with several forms of psychopathology, as well as brain/head 
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size, results for the Discordant subset were somewhat surprising. For example, we had anticipated that 
the Discordant subset might be significantly related to personality, as a non-cognitive trait that could 
promote greater educational attainment. However, correlations with conscientiousness, openness, and 
neuroticism were stronger for the Concordant as opposed to the Discordant subset.  
On the other hand, significant correlations for the Discordant subset were observed with risk for 
autism, which has previously been shown to demonstrate a counter-intuitive positive genetic correlation 
with cognition89. Given that variants within the Discordant subset tend to index regulation of synaptic 
function and pruning processes, our results suggest that these mechanisms be investigated with respect 
to their impact on autism, eating disorders, and bipolar disorder. Moreover, it is noteworthy that 
autism, despite being a neurodevelopmental disorder, did not demonstrate a significant genetic 
correlation with the Concordant subset, indicating that it does not share the specific 
neurodevelopmental pathways implicated in the common variant genetic overlap between 
schizophrenia risk and impaired cognition.  It is also intriguing that bipolar disorder demonstrated a very 
similar pattern of GNOVA results to schizophrenia, despite prior reports that bipolar disorder is not 
significantly correlated at the genetic level with general cognitive ability89,90. Thus, our approach was 
able to refine components of neurodevelopment and synaptic function that are shared across cognitive 
phenotypes, schizophrenia, and bipolar disorder. Further research is needed to identify components of 
cognition that differentiate schizophrenia and bipolar disorder.  
 One limitation of this study is only common SNPs (MAF > 0.01) were examined. The genetic 
architecture of cognitive ability and educational attainment is composed of causal variants in LD with 
common SNPs (cognitive ability h2 = 22.7%, education h2 = 15.6%) as well as with causal variants in LD 
with rare and less common SNPs (cognitive ability h2 = 31.3%, education h2 = 28.1%), with rarer variants 
making greater contribution to cognitive differences than more common variants91. Rare variants are 
also known to explain some of the differences in schizophrenia prevalence51. However, GNOVA, used to 
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identify genetic correlations across data independent data sets using summary GWAS data, can only 
capture the contributions made by common genetic effects. Future work aiming to investigate the 
concordant and discordant effect of rare variants across cognitive ability, schizophrenia, and education 
is needed92. Additionally, the input GWAS for ASSET were of somewhat different sample sizes and 
power, with the cognitive GWAS demonstrating smaller mean effect sizes compared to schizophrenia 
and educational attainment; the effects of such differences on ASSET results are not fully understood, 
although ASSET has been benchmarked as the best available approach to handling non-uniform 
distribution of effect sizes39. 
 Having demonstrated the utility and validity of the ASSET approach, future studies are planned 
that can further exploit this method using larger, and more varied, input GWAS. Recent studies have 
demonstrated that genetic correlations exist across seemingly disparate brain-related phenotypes.93 
However, such genetic correlations only describe the average genetic effect between pairs of traits. As 
such, they are not informative as to which variants are associated across traits, nor if a minority of these 
variants have effects across traits that are the opposite of what would be expected by the direction of 
the genetic correlation. The application of the ASSET approach to these data sets would help to move 
beyond the analysis of shared genetic variance, and begin to identify shared genetic variants which, as 
shown in the current study, may be composed of variants with different combinations of protective and 
deleterious effects. Future studies, with additional statistical techniques, incorporating rare variants, 
and novel annotation resources, are needed to further decompose the early neurodevelopmental and 
adult synaptic pathways highlighted in the present report. 
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Figure Legends 
Figure 1. Design of the present study. 
(A) Input GWAS studies used for ASSET analysis. (B) Definition of Concordant and Discordant SNP 
subsets. Concordant SNPs have alleles which demonstrate negative effects on cognitive ability, 
educational attainment, and schizophrenia risk (i.e., increased schizophrenia risk, reverse-coded for 
consistency). Discordant SNPs have alleles which demonstrate paradoxical effects on educational 
attainment and schizophrenia (i.e., higher educational attainment and increased schizophrenia risk, 
reverse-coded). Y-Axis on the forest plots represent different input summary statistics for Cognition, 
Education and Schizophrenia.  
Figure 2. Genetic correlations with schizophrenia, for SNPs demonstrating heterogeneity of effects 
between (A) cognitive ability and (B) educational attainment.  
Genetic correlation was carried out using GNOVA. Error bars represent standard errors. Education: 
Okbay PMID 27225129; Cognition: Lam PMID 29186694; Schizophrenia (Ripke): PGC Schizophrenia 
Working Group PMID  25056061. 
Figure 3. Manhattan plots for ASSET results.  
ASSET meta-analysis outputs: (A) All subsets. (B) Concordant subset. (C) Discordant subset 
Figure 4. Venn diagram comparing significant ASSET loci to significant loci from input GWASs. 
Education: Okbay PMID 27225129; Cognition: Lam PMID 29186694; Schizophrenia (Ripke): PGC 
Schizophrenia Working Group PMID  25056061; ASSET: Results from ASSET meta-analysis. 
Figure 5. S-PrediXcan Transcriptome-wide association results  
(A) Concordant and (B) Discordant subsets. 
Figure 6. Genetic correlations for Concordant and Discordant subsets with other relevant phenotypes. 
Genetic correlation was carried out using GNOVA. Error bars represent standard errors. Summary 
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statistics of selected phenotypes were downloaded from LD-hub and Psychiatric Genomics Consortium 
websites. See Web resources for further detail.  
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Web Resources 
 
OMIM https://www.omim.org/ 
ASSET https://dceg.cancer.gov/tools/analysis/asset 
LDSC https://github.com/bulik/ldsc 
FUMA http://fuma.ctglab.nl/ 
MAGMA https://ctg.cncr.nl/software/magma 
S-Predixcan https://github.com/hakyimlab/MetaXcan 
VEP http://grch37.ensembl.org/Homo_sapiens/Tools/VEP 
Social Science Genetic Association Consortium https://www.thessgac.org/data  
Genes2Cognition Database http://www.genes2cognition.org  
PredictDB http://predictdb.org/  
Psychiatric Genomics Consortium https://www.med.unc.edu/pgc/results-and-downloads/ 
LD-hub http://ldsc.broadinstitute.org/ldhub/ 
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